GoodRx Holdings financials
$3.31−1.19%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $200.4M | $194.0M | $194.8M | $196.0M | $203.1M | $203.0M | $198.6M | $195.3M | $200.6M | $197.9M | $196.6M | $180.0M |
| Gross profit | $179.4M | $173.8M | $177.3M | $182.6M | $189.7M | $189.6M | $186.4M | $183.6M | $188.7M | $185.4M | $181.5M | $161.2M |
| Gross margin | 89.5% | 89.6% | 91.0% | 93.2% | 93.4% | 93.4% | 93.9% | 94.0% | 94.1% | 93.7% | 92.3% | 89.6% |
| Operating income | $23.6M | $14.0M | $22.7M | $14.6M | $26.8M | $23.4M | $18.2M | $20.4M | $19.9M | $7.4M | -$18.3M | -$38.3M |
| Net income | $8.5M | $1.2M | $5.4M | $1.1M | $12.8M | $11.1M | $6.7M | $4.0M | $6.7M | -$1.0M | -$25.9M | -$38.5M |
| Net margin | 4.3% | 0.6% | 2.8% | 0.6% | 6.3% | 5.4% | 3.4% | 2.0% | 3.3% | −0.5% | −13.2% | −21.4% |
| Diluted EPS | $0.02 | $0.00 | $0.02 | $0.00 | $0.04 | $0.03 | $0.02 | $0.01 | $0.02 | $0.00 | $-0.06 | $-0.09 |
| EBITDA | $45.9M | $35.8M | $45.8M | $36.1M | $46.5M | $44.3M | $37.3M | $37.9M | $36.8M | $23.3M | -$18.3M | -$5.3M |
| Operating cash flow | $80.8M | $11.8M | $32.9M | $76.0M | $49.6M | $9.4M | $44.7M | $86.9M | $9.7M | $42.6M | $15.9M | $60.3M |
| Free cash flow | $80.5M | $10.7M | $17.1M | $58.0M | $49.2M | $9.3M | $28.1M | $71.0M | -$7.5M | $22.0M | $3.0M | $46.6M |
| Diluted shares | 348.1M | 341.4M | 343.3M | 347.8M | 357.2M | 379.7M | 405.4M | 388.5M | 384.7M | 390.0M | 401.1M | 413.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $296.1M | $235.7M | $261.8M | $273.5M | $281.3M | $301.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $486.6M | $487.4M | $488.3M | $489.1M | $490.0M | $490.8M |
| Total assets | $2.34B | $2.02B | $1.40B | $1.33B | $1.32B | $1.30B |
| Total liabilities | $1.70B | $1.40B | $787.8M | $724.8M | $675.7M | $640.9M |
| Shareholders' equity | $647.6M | $622.0M | $616.3M | $600.7M | $643.0M | $654.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology